News

A Case of MPGN Caused by MGRS

By

By Nilson Feliz, MD, Manuel Fernandez, MD, Lisa M. Sebastian, MD, Roberto L. Collazo-Maldonado, MD, FACP A 60-year old African American man was referred for evaluation of nephrotic syndrome. His past medical history was positive for HTN, DM, and Hepatitis C — successfully treated with ombitasvir/periteprevir/dasabuvir for three months. His hepatitis C viral load was … Continued

Screening for Chronic Kidney Disease

By

By Harold Szerlip, MD MS(ED), FACP, FCCP, FASN, FNKF, CCRP and Bernard V. Fischbach, MD, CCRP Chronic kidney disease (CKD) is a general term for diverse disorders affecting kidney structure and function with a variable clinical presentation. The Centers for Disease Control (CDC) estimates that more than 20 million adults, in the U.S., may have … Continued

RDRI Begins First Clinical Trial

By

The Renal Disease Research Institute (RDRI) is a new research entity affiliated with Dallas Nephrology Associates. There is significant ethical oversight of this entity through RDRI’s Board of Managers and Scientific Review Committee. Currently, there are several potential clinical research trials in the pipeline. RDRI’s first active clinical trial is a device trial spearheaded by … Continued

Dr. Hull Receives 2016 Simmons Legacy Award

By

Dr. Alan R. Hull, former President of Dallas Nephrology Associates, Receives Prestigious Award Congratulations to Dr. Alan R. Hull upon his receipt of the prestigious 2016 Harold and Annette Simmons Legacy Award.  The award is presented each year to a key philanthropic individual or family who is committed to the well-being of the North Texas … Continued

Dr. Kim Rice Addresses Outcomes in Kidney Transplantation in The New England Journal of Medicine

By

Dr. Kim M. Rice recently co-authored, Belatacept and Long-Term Outcomes in Kidney Transplantation, in The New England Journal of Medicine which concluded that seven years after transplantation, patient and graft survival and the mean eGFR were significantly higher with belatacept than with cyclosporine. Dr. Rice joined Dallas Nephrology Associates in 1998 and is board certified … Continued

Dr. Daniel Richey Presents at Texas Osteopathic Medical Association 2016 Annual Conference

By

Dr. Daniel S. Richey recently presented on Glomerular Filtration Rate during the Texas Osteopathic Medical Association (TOMA) 2016 MidWinter Conference which occurred January 22-24, 2016 at the Omni Dallas Park West Hotel in Dallas, TX. TOMA’s annual conference is attended by dedicated osteopathic professionals vitally interested in improving their practice and osteopathic medicine through the … Continued

Dr. Kim M. Rice Presents at Kidney Week 2015

By

Dr. Kim M. Rice recently presented on Improving Outcomes in Transplant during Kidney Week 2015.  American Society of Nephrology’s annual conference, Kidney Week, is attended by the most influential kidney professionals and occurred November 3-8, 2015 in San Diego, CA. Dr. Rice’s presentation, Belatacept Patients Had Superior Graft Survival Compared with Cyclosporine Patients: Final Results … Continued

Methodist Teaching Award Presented to Dr. Lisa Sebastian

By

Congratulations to Lisa Sebastian, MD as the recipient of the Teaching Award of the Year presented by Methodist Dallas Hospital Fellowship.  Dr. Sebastian was honored with this distinguished award for her outstanding contribution to Methodist Dallas Nephrology fellowship teaching program during their 79th Methodist Dallas Graduate Medical Education (GME) graduation ceremony which was held on … Continued